Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Prestige Consumer Healthcare Inc.PBH · Entity 4350 | Director | August 04, 2026 | August 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Prestige Consumer Healthcare Inc.
Report date August 04, 2026 · Filed August 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 54,575 |
Reported balance
After 2026-08-04 transaction · row 1
1 source rowRow 1 · 2026-08-04 · Grant · Acquired 2,981 · Balance 54,575 F1: The Reporting Person received 2,981 restricted stock units equal to $155,000 divided by the closing stock price of $52.00 on August 4, 2026, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person received 2,981 restricted stock units equal to $155,000 divided by the closing stock price of $52.00 on August 4, 2026, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 04, 2026 Filed Aug 5, 2026 20:06 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 2,981 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-091079 · tm2622318-1_4seq1.xml · nonDerivative · entry 1 BYOM JOHN E · CIK 0001202329 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,575 F1 · shares: The Reporting Person received 2,981 restricted stock units equal to $155,000 divided by the closing stock price of $52.00 on August 4, 2026, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control. Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 21:01 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | SaleCommon Stock, par value $0.01 per share | 3,000 | $59.35 | $178,050.00 |
DisclosureSEC source: 0001104659-25-116419 · tm2532302-1_4seq1.xml · nonDerivative · entry 1 BYOM JOHN E · CIK 0001202329 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,594 F1 · shares: Multiple lots for the same price for this transaction have been combined. Read SEC document |
| August 05, 2025 Filed Aug 6, 2025 20:01 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 2,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-074694 · tm2522759-1_4seq1.xml · nonDerivative · entry 1 BYOM JOHN E · CIK 0001202329 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,594 F1 · shares: The Reporting Person received 2,094 restricted stock units equal to $155,000 divided by the closing stock price of $74.04 on August 5, 2025, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control. Read SEC document |
| August 06, 2024 Filed Aug 7, 2024 20:03 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 2,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-086746 · tm2421115-3_4seq1.xml · nonDerivative · entry 1 BYOM JOHN E · CIK 0001202329 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,500 F1 · shares: The Reporting Person received 2,202 restricted stock units equal to $150,000 divided by the closing stock price of $68.13 on August 6, 2024, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 18:00 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 2,295 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-087187 · tm2322776-1_4seq1.xml · nonDerivative · entry 1 BYOM JOHN E · CIK 0001202329 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,298 F1 · shares: The Reporting Person received 2,295 restricted stock units equal to $150,000 divided by the closing stock price of $65.37 on August 1, 2023, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control. Read SEC document |
| August 02, 2022 Filed Aug 3, 2022 21:16 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 2,495 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-085705 · tm2222537-1_4seq1.xml · nonDerivative · entry 1 BYOM JOHN E · CIK 0001202329 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,003 F1 · shares: The Reporting Person received 2,495 restricted stock units (equal to $150,000 divided by the closing stock price of $60.12 on August 2, 2022) in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of (i) the Reporting Person's death, (ii) the Reporting Person's separation from service or (iii) change in control. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 22:59 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 2,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-100926 · tm2124298-6_4seq1.xml · nonDerivative · entry 1 BYOM JOHN E · CIK 0001202329 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,508 F1 · shares: The Reporting Person received 2,808 restricted stock units (equal to $150,000 divided by the closing stock price of $53.42 on August 3, 2021) in connection with the Issuer's director compensation program. The restricted stock units vest immediately upon grant and will be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of (i) the Reporting Person's death, (ii) the Reporting Person's separation from service or (iii) change in control. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 21:24 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 3,732 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-091553 · tm2023357d8_4.xml · nonDerivative · entry 1 BYOM JOHN E · CIK 0001202329 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,700 F1 · shares: The Reporting Person received 3,732 restricted stock units (equal to $145,000 divided by the closing stock price of $38.86 on August 4, 2020) in connection with the Issuer's director compensation program. The restricted stock units vest immediately upon grant and will be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of (i) the Reporting Person's death, (ii) the Reporting Person's separation from service or (iii) change in control. Read SEC document |
| July 30, 2019 Filed Aug 1, 2019 20:17 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 4,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-037207 · tv526528_4.xml · nonDerivative · entry 1 BYOM JOHN E · CIK 0001202329 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,968 F1 · shares: The Reporting Person received 4,183 restricted stock units (equal to $145,000 divided by the closing stock price of $34.67 on July 30, 2019) in connection with the Issuer's director compensation program. The restricted stock units vest immediately upon grant and will be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of (i) the Reporting Person's death, (ii) the Reporting Person's separation from service or (iii) change in control. Read SEC document |
| July 31, 2018 Filed Aug 1, 2018 20:01 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 3,779 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-041348 · tv499902_4.xml · nonDerivative · entry 1 BYOM JOHN E · CIK 0001202329 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,785 F1 · shares: The Reporting Person received 3,779 restricted stock units (equal to $135,000 divided by the closing stock price of $35.73 on July 31, 2018) in connection with the Issuer's director compensation arrangement. The restricted stock units vest immediately upon execution and acceptance of the award and shall be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of the Reporting Person's (i) death, (ii) disability or (iii) the six-month anniversary of the date on which the Reporting Person's Board membership ceases for reasons other than death or disability. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 19:30 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 2,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-040280 · v472272_4.xml · nonDerivative · entry 1 BYOM JOHN E · CIK 0001202329 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,006 F1 · shares: The Reporting Person received 2,564 restricted stock units (equal to $135,000 divided by the closing stock price of $52.64 on August 1, 2017) in connection with the Issuer's director compensation arrangement. The restricted stock units vest immediately upon execution and acceptance of the award and shall be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of the Reporting Person's (i) death, (ii) disability or (iii) the six-month anniversary of the date on which the Reporting Person's Board membership ceases for reasons other than death or disability. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.